Immunoassay Market Research Report - Global Forecast till 2027

Global Immunoassay Market Research Report: by Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Technology [Radioimmunoassay (RIA), Enzyme-linked Immunosorbent Assay (ELISA), Enzyme-linked Fluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Rapid Test, Others], Indication (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Diseases, Autoimmune Diseases, Others), End User (Hospitals, Clinical Laboratories, Blood Banks, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others) and Region - Forecast till 2027

ID: MRFR/HC/4385-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2019-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Global Immunoassay Market is expected to register a healthy CAGR over the forecast period. The immunoassay market size accounted for USD 18,626.7 million in 2018 and is projected to register a CAGR of 5.9% during the forecast period. Immunoassay is a bioanalytical method to detect or measure specific proteins or other substances through their properties as antigens or antibodies. Immunoassays use antigen-antibody reaction to detect the concentration of a wide range of biological substances in the blood and other fluids. Some of the prominent market drivers are the rising worldwide prevalence of chronic and infectious diseases, increasing adoption of immunoassay-based point-of-care (POC) testing and rapid testing, flourishing biotechnology and pharmaceutical sector, and technological advancements in immunoassay instruments and the introduction of novel automated systems. For instance, according to the American Chemical Society (ACS), in the US, clinical laboratories perform more than 7 billion tests on blood, urine, and other samples from patients every year, which is supporting the market growth.


On the flip side, lack of reimbursement policies and rigorous regulatory requirements for the approval of immunoassay instruments and consumables from respective authorities are anticipated to restrict the market growth during the forecast period.


Major Key Players 


Some of the Major leading players in the global immunoassay market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.p.A.


Intended Audience



  • Manufacturers and distributors of immunoassay instruments and consumables

  • Medical diagnostic suppliers

  • Venture capitalists

  • Pharmaceutical and biopharmaceutical companies

  • Medical devices companies

  • Research and academic institutes

  • Healthcare facilities

  • Association and government bodies

  • Market research and consulting service providers

  • Corporate entities


Market Segmentation


The global immunoassay market has been segmented into product, technology, indication, end user, and region.


By product, the market has been segmented into reagents and kits, analyzers/instruments, software, and services. The reagents and kits segment was the largest value contributor in the global immunoassay market in 2018 due to the rising incidence of chronic and infectious diseases, growing use of reagents and kits along with its repetitive purchase by the users.


On the basis of technology, the market has been divided into radioimmunoassay (RIA), enzyme-linked immunosorbent assay (ELISA), enzyme-linked fluorescent assay (ELFA), chemiluminescence immunoassay (CLIA), rapid test, and others.


By indication, the global immunoassay market has been categorized into therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious diseases, autoimmune diseases, and others.


Based on end user, the market has been classified into hospitals, clinical laboratories, blood banks, pharmaceutical and biotechnology companies, academic and research institutes, and others.


The global immunoassay market has been segmented on the basis of region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The immunoassay market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.


The European immunoassay market has been segmented into Western Europe and Eastern Europe. The Western Europe immunoassay market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The immunoassay market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The immunoassay market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Geographically, the Americas held substantial market share in 2018 attributed to the availability of government funds, presence of key market players, surging number of research projects in laboratories coupled with increasing adoption of immunoassay in clinical diagnostics in the US and Canada. Companies such as Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Danaher Corporation, Abbott Laboratories, and Quidel Corporation are headquartered in the US, thereby enabling early market initiation along with prompt product supply and service delivery.


Global Immunoassay Market Share (%), by Region, 2018  Immunoassay Market_Image


Source: White Papers, Company Presentations, Annual Reports, and MRFR Analysis


Europe would be the second-largest value contributor in the global immunoassay market size throughout the forecast period attributed to growing adoption in diagnostic measures, rising use of chemiluminescent immunoassay, and a prospering growth in the pharmaceutical and biotechnology companies in the UK, Germany, and France. As per data published by the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2016, Europe accounted for 21.5% of world pharmaceutical sales that was increased to 22.2% of global pharmaceutical sales in 2017.


Asia-Pacific is expected to represent significant market growth during next seven years owing to growing geriatric population coupled with rising prevalence of chronic diseases, increasing awareness about immunoassay tests, growth in healthcare spending in emerging countries, namely, India, China, and Australia. The number of the elderly population in the Asia-Pacific region is rising at an unprecedented rate. The statistics presented by United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP) stated that in 2016, about 12.4% of the Asia-Pacific population was 60 years or older, which is projected to increase to more than a quarter (1.3 billion individuals) by the end of 2050.


The immunoassay market in the Middle East & Africa would witness the modest market growth rate from 2019 to 2025. The Middle East would spearhead the market attributed to growth in healthcare sector along with developing healthcare infrastructure in the Gulf Cooperation Council (GCC) countries such as Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, and Oman.


Global Immunoassay Market, by Product



  • Reagents and Kits

  • Analyzers/Instruments

  • Software and Services


Global Immunoassay Market, by Technology



  • Radioimmunoassay (RIA)

  • Enzyme-linked Immunosorbent Assay (ELISA)

  • Enzyme-linked Fluorescent Assay (ELFA)

  • Chemiluminescence Immunoassay (CLIA)

  • Rapid Test

  • Others


Global Immunoassay Market, by Indication



  • Therapeutic Drug Monitoring

  • Oncology

  • Cardiology

  • Endocrinology

  • Infectious Diseases

  • Autoimmune Diseases

  • Others


Global Immunoassay Market, by End User



  • Hospitals

  • Clinical Laboratories

  • Blood Banks

  • Pharmaceutical and Biotechnology Companies

  • Academic and Research Institutes

  • Others


Global Immunoassay Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




The report for Global Immunoassay Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 18,626.7 Million (2025)
  CAGR   5.9% (2019-2025)
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product, Indication, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, bioMérieux SA, Siemens Healthineers, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Sysmex Corporation, Ortho-Clinical Diagnostics/Carlyle Group, Quidel Corporation, and DiaSorin S.P.A.
  Key Market Opportunities   Increasing Adoption of immunoassay-based point-of-care (POC) testing and rapid testing
  Key Market Drivers   The Rising prevalence of chronic and infectious diseases


Frequently Asked Questions (FAQ) :


Immunoassay Market was valued at over USD 18.6 billion in 2018.

Immunoassay Market is expected to exhibit a strong 5.9% CAGR over the forecast period from 2019 to 2025.

Immunoassays are used to detect the concentration of a wide range of biological substances in blood.

The rising prevalence of chronic and infectious diseases is the major driver for the global immunoassay market.

Lack of support from reimbursement agencies and strict regulatory requirements are the major restraint on the global immunoassay market.

Table of Contents


Chapter 1 Executive Summary

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope of the Study

2.3 Assumptions and Limitations

2.4 Market Structure

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6 Global Immunoassay Market, by Product

6.1 Introduction

6.2 Reagents and Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Analyzers/Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Software and Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7 Global Immunoassay Market, by Technology

7.1 Introduction

7.2 Radioimmunoassay (RIA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Enzyme-linked Immunosorbent Assay (ELISA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Enzyme-linked Fluorescent Assay (ELFA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Chemiluminescence Immunoassay (CLIA)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Rapid Test

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8 Global Immunoassay Market, by Indication

8.1 Introduction

8.2 Therapeutic Drug Monitoring

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Oncology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Cardiology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Endocrinology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Infectious Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7 Autoimmune Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.8 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9 Global Immunoassay Market, by End User

9.1 Introduction

9.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Clinical Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Blood Banks

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.6 Academic and Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.7 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10 Global Immunoassay Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Developments & Strategies

Chapter 12 Company Profiles

12.1 Thermo Fisher Scientific Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financial Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.1.6 Key Strategies

12.2 F. Hoffmann-La Roche Ltd

12.3 Siemens Healthineers

12.4 bioMérieux SA

12.5 Becton, Dickinson and Company

12.6 Danaher Corporation

12.7 Abbott Laboratories

12.8 Merck KGaA

12.9 Sysmex Corporation

12.10 Ortho Clinical Diagnostics/Carlyle Group

12.11 Quidel Corporation

12.12 DiaSorin S.p.A.

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Immunoassay Industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Global Immunoassay Market Synopsis, 2020-2027

Table 2 Global Immunoassay Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Immunoassay Market, by Region, 2020-2027 (USD Million)

Table 4 Global Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 5 Global Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 6 Global Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 7 Global Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 8 North America: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 10 North America Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 11 North America Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 12 US: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 13 US: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 14 US Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 15 US Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 16 Canada: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 17 Canada: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 18 Canada Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 19 Canada Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 20 Latin America: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 21 Latin America: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 22 Latin America Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 23 Latin America Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 24 Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 25 Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 26 Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 27 Europe Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 28 Western Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 29 Western Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 30 Western Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 31 Western Europe Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 32 Eastern Europe: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 33 Eastern Europe: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 34 Eastern Europe Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 35 Eastern Europe Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 38 Asia-Pacific Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 39 Asia-Pacific Immunoassay Market, by End User, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Immunoassay Market, by Product, 2020-2027 (USD Million)

Table 41 Middle East & Africa: Immunoassay Market, by Technology, 2020-2027 (USD Million)

Table 42 Middle East & Africa Immunoassay Market, by Indication, 2020-2027 (USD Million)

Table 43 Middle East & Africa Immunoassay Market, by End User, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Immunoassay Market

Figure 3 Segmentation Market Dynamics for Global Immunoassay Market

Figure 4 Global Immunoassay Market Share, by Product, 2020

Figure 5 Global Immunoassay Market Share, by Technology, 2020

Figure 6 Global Immunoassay Market Share, by Indication, 2020

Figure 7 Global Immunoassay Market Share, by End User, 2020

Figure 8 Global Immunoassay Market Share, by Region, 2020

Figure 9 North America: Immunoassay Market Share, by Country, 2020

Figure 10 Europe: Immunoassay Market Share, by Country, 2020

Figure 11 Asia-Pacific: Immunoassay Market Share, by Country, 2020

Figure 12 Middle East & Africa: Immunoassay Market Share, by Country, 2020

Figure 13 Global Immunoassay Market: Company Share Analysis, 2020 (%)

Figure 14 Thermo Fisher Scientific Inc.: Key Financials

Figure 15 Thermo Fisher Scientific Inc.: Segmental Revenue

Figure 16 Thermo Fisher Scientific Inc.: Geographical Revenue

Figure 17 F. Hoffmann-La Roche Ltd: Key Financials

Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 20 Siemens Healthineers: Key Financials

Figure 21 Siemens Healthineers: Segmental Revenue

Figure 22 Siemens Healthineers: Geographical Revenue

Figure 23 bioMérieux SA: Key Financials

Figure 24 bioMérieux SA: Segmental Revenue

Figure 25 bioMérieux SA: Geographical Revenue

Figure 26 Becton, Dickinson and Company: Key Financials

Figure 27 Becton, Dickinson and Company: Segmental Revenue

Figure 28 Becton, Dickinson and Company: Geographical Revenue

Figure 29 Danaher Corporation: Key Financials

Figure 30 Danaher Corporation: Segmental Revenue

Figure 31 Danaher Corporation: Geographical Revenue

Figure 32 Abbott Laboratories: Key Financials

Figure 33 Abbott Laboratories: Segmental Revenue

Figure 34 Abbott Laboratories: Geographical Revenue

Figure 35 Merck KGaA: Key Financials

Figure 36 Merck KGaA: Segmental Revenue

Figure 37 Merck KGaA: Geographical Revenue

Figure 38 Sysmex Corporation: Key Financials

Figure 39 Sysmex Corporation: Segmental Revenue

Figure 40 Sysmex Corporation: Geographical Revenue

Figure 41 Ortho Clinical Diagnostics/Carlyle Group: Key Financials

Figure 42 Ortho Clinical Diagnostics/Carlyle Group: Segmental Revenue

Figure 43 Ortho Clinical Diagnostics/Carlyle Group: Geographical Revenue

Figure 44 Quidel Corporation: Key Financials

Figure 45 Quidel Corporation: Segmental Revenue

Figure 46 Quidel Corporation: Geographical Revenue

Figure 47 DiaSorin S.p.A.: Key Financials

Figure 48 DiaSorin S.p.A.: Segmental Revenue

Figure 49 DiaSorin S.p.A.: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.